Research.Patient.info

Advanced Urothelial Carcinoma and Other Solid Tumors with Activating FGFR3 Gene Alterations research hub

1 indexed studies · 0 currently recruiting

ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
A Multicenter, Open-label Phase 1/2 Study of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors with Activating FGFR3 Gene Alterations (SURF-301)
Spain · France · Italy